Monitoring Agency Report for Quarter Ended September 30, 2026.

November 5, 2026 The Manager The Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers Exchange Plaza, Plot No. C/1, G Block, Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai - 400051 Scrip Code (BSE): 544009 Symbol: BLUEJET Sub.: Monitoring Agency Report for the quarter ended September 30, 2026. Dear Sir / Ma'am, Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report for the quarter ended September 30, 2026 issued by CARE Ratings Limited in respect of utilization of funds raised through Qualified Institutional Placement (QIP) of the Company, The said report is duly reviewed, approved and taken on record by the Audit Committee and the Board of Directors of the Company in their meeting held today, i.e, November 05, 2026. The above information will be made available on the website of the Company: www.bluejethealthcare.com Kindly take the same on your record. Thanking you, Yours faithfully, For Blue Jet Healthcare Limited Sweta Poddar Company Secretary & Compliance Officer Mem. No. F12287 Monitoring Agency Report No. CARE/HO/GEN/2026-27/1215 The Board of Directors Blue Jet Healthcare Limited 701, 702, 7th Floor, Bhumiraj Costarica Sector 18, Sanpada, Thane, Navi Mumbai Maharashtra 400705 November 05, 2026 Dear Sir, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the QIP of Blue Jet Healthcare Limited (“the Company”) We write in our capacity of Monitoring Agency for the QIP for the amount aggregating to ₹800 crore of the company and refer to our duties cast under 173A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated July 06, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully Ashish A Kambli Associate Director Ashish.K@careedge.in Monitoring Agency Report Report of the Monitoring Agency Name of the issuer: Blue Jet Healthcare Limited For quarter ended: September 30, 2026. Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: NIL (b) Range of Deviation: NIL Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name of the Authorized Signatory: Ashish A Kambli Designation of Authorized person/Signing Authority: Associate Director Monitoring Agency Report ft Monitoring Ag Report 1) Issuer Details: Name of the issuer : Blue Jet Healthcare Ltd Name of the promoter : Akshay Bansarilal Arora, Shiven Akshay Arora, Archana Akshay Arora Industry/sector to which it belongs : Pharmaceuticals and biotechnology 2) Issue Details Issue Period : July 06, 2026 to July 09, 2026 Type of issue (public/rights) : QIP Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in crore) : ₹800 crore 3) Details of the arrangement made to ensure the monitoring of the issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors The utilization during the quarter remains in line with the offer document. FD creation out of current account: Out of the total Bank Statements, Management Whether all utilization is as per the disclosures unutilized funds parked in fixed deposits (FDs) amounting No comments Yes confirmation, CA certificate* and in the Offer Document? to ₹250 crore, FDs worth ₹150 crore have been created received Placement document from current account held with HDFC Bank wherein the amount has been transferred from monitoring account held with Kotak Mahindra Bank. Whether shareholder approval has been Bank Statements, Management Not No comments obtained in case of material deviations# from confirmation, CA certificate* and No comments applicable received expenditures disclosed in the Offer Document? Placement document Whether the means of finance for the Management confirmation and CA No comments No No comments disclosed objects of the issue have changed? certificate* received Is there any major deviation observed over the Not No comments Not applicable Not applicable as this is the first monitoring agency report earlier monitoring agency reports? applicable received Whether all Government/statutory approvals Management confirmation and CA The company has applied for the required approvals for No comments related to the object(s) have been obtained? certificate* the capex object as per the offer document received Whether all arrangements pertaining to Not Management confirmation and CA No comments No comments Monitoring Agency Report ft Monitoring Ag Report Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors technical assistance/collaboration are in applicable certificate* received operation? Are there any favorable/unfavorable events Not Management confirmation and CA No comments No comments affecting the viability of these object(s)? applicable certificate* received Management confirmation and CA MA notes, the company has utilized ₹168.44 crore of Is there any other relevant information that certificate* proceeds towards raw material & packing material No comments may materially affect the decision making of Yes purchases as compared to its raw material cost of ₹208.75 received the investors? crore in Q1FY27. *Chartered Accountant certificate from H. H. Chimthanawala & Co., Chartered Accountants dated November 02, 2026. #Where material deviation may [Showing first 8,000 characters — download PDF for full document]